Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Sarcoma 1 Non-squamous Non-small-cell Lung Cancer 1 Lung Neoplasms 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Tumors 1 Advanced Solid Tumor 1 Advanced NSCLC 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Tumors × camrelizumab × Clear all

NCT05799183 2024-12-31

A SHR-1210 BE Study on Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Terminated

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡